Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients

J Exp Med. 2024 Oct 7;221(10):e20240637. doi: 10.1084/jem.20240637. Epub 2024 Sep 24.

Abstract

Tick-borne encephalitis (TBE) virus (TBEV) is transmitted to humans via tick bites. Infection is benign in >90% of the cases but can cause mild (<5%), moderate (<4%), or severe (<1%) encephalitis. We show here that ∼10% of patients hospitalized for severe TBE in cohorts from Austria, Czech Republic, and France carry auto-Abs neutralizing IFN-α2, -β, and/or -ω at the onset of disease, contrasting with only ∼1% of patients with moderate and mild TBE. These auto-Abs were found in two of eight patients who died and none of 13 with silent infection. The odds ratios (OR) for severe TBE in individuals with these auto-Abs relative to those without them in the general population were 4.9 (95% CI: 1.5-15.9, P < 0.0001) for the neutralization of only 100 pg/ml IFN-α2 and/or -ω, and 20.8 (95% CI: 4.5-97.4, P < 0.0001) for the neutralization of 10 ng/ml IFN-α2 and -ω. Auto-Abs neutralizing type I IFNs accounted for ∼10% of severe TBE cases in these three European cohorts.

MeSH terms

  • Adult
  • Aged
  • Antibodies, Neutralizing* / immunology
  • Austria / epidemiology
  • Autoantibodies* / immunology
  • Tschechische Republik
  • Encephalitis Viruses, Tick-Borne / immunology
  • Encephalitis, Tick-Borne* / immunology
  • Female
  • Humans
  • Interferon Type I* / immunology
  • Male
  • Middle Aged

Substances

  • Interferon Type I
  • Autoantibodies
  • Antibodies, Neutralizing